hims stock target price

Historical Ratings and Targets

Date	Upside / Downside	Analyst Firm	Price Target Change	Rating Change
2022-05-26	25.26%	Piper Sandler	$8.00 $6.00	Maintains
2022-05-10	25.26%	Citigroup	$9.00 $6.00	Maintains
2022-04-14	108.77%	Guggenheim	$10.00	Initiates Coverage On
2022-03-10	46.14%	Deutsche Bank	$7.00	Initiates Coverage On

Jul 3 2022

Full Answer

What is the price target for Hims&hers health?

The average twelve-month price target for Hims & Hers Health is $11.20 with a high price target of $16.00 and a low price target of $7.00. Learn more

Does Hims&hers health stock outperform other medical stocks?

MarketBeat users like Hims & Hers Health stock less than the stock of other Medical companies. 47.83% of MarketBeat users gave Hims & Hers Health an outperform vote while medical companies recieve an average of 67.44% outperform votes by MarketBeat users. Does Hims & Hers Health's stock price have much upside?

Does Hims’ stock price reflect its true potential?

Ultimately, Hims stock price will reflect its true potential (as long as the company continues to execute). A company’s value is calculated by discounting all its future cash flows. The further into the future a company’s projected cash flows are, the more of an impact interest rates have mathematically.

Where can I buy shares of Hims?

Shares of HIMS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here.

Is HIMS a good stock buy?

The financial health and growth prospects of HIMS, demonstrate its potential to underperform the market. It currently has a Growth Score of C. Recent price changes and earnings estimate revisions indicate this would not be a good stock for momentum investors with a Momentum Score of D.

Why is HIMS stock so low?

HIMS has fallen 68% from its 52-week high of $25.40 to $8.15 as of writing this article. This was caused by a combination of factors including what has been a decimation of sentiment on companies that went public through the SPAC route.

How many shares of HIMS are there?

206.06 million sharesShare Statistics HIMS has 206.06 million shares outstanding. The number of shares has increased by 32.41% in one year.

What sector is HIMS in?

("Hims & Hers", NYSE: HIMS), a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals and provides access to related prescription fulfillment, today reported financial results for the first quarter ending March 31, 2022.

Is hims a meme stock?

However, Hims is far from being a meme stock. It's an interesting, modern company with what seems to be a future-proof business model, offering healthcare services that will still be in demand in years to come. The fact that the stock price is low can be seen as both a risk and an opportunity.

What is hims company?

December 2021) Hims & Hers Health, Inc. is an American telehealth company that sells prescription and over-the-counter drugs online, as well as personal care products. The company is best known for selling generic treatments for erectile dysfunction and hair loss.

How much is the company Roman worth?

It also places the company at a valuation of $5 billion, CEO Zachariah Reitano told Bloomberg. The New York-based company got its start in 2017 as Roman, with an initial focus on erectile dysfunction and other men's health and wellness issues often accompanied by stigma.

How do you buy stocks on wish?

Shares of WISH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

Is Hims undervalued?

Hims Hers Health retains a regular Real Value of $7.1 per share. The prevalent price of the firm is $5.72. At this time, the firm appears to be undervalued.

Who created Hims?

Andrew DudumHims / Founder

When was Hims founded?

November 2017Hims / Founded

Did Hims go public?

Digital Health Startup Hims & Hers Goes Public In $1.6 Billion SPAC Deal.

Will included health go public?

Exclusive: Grand Rounds, now Included Health, is gearing up for an IPO in early 2022. Included Health's public debut is one to watch after digital-health stocks have drawn investor skepticism in the second half of 2021.

What does him stand for in medical?

Health information managers (HIM) organize, oversee, and protect patient health information data which includes symptoms, diagnoses, medical histories, test results, and procedures.

What is the full form of Hims?

Health Information Management Service (HIMS)

What is Hims & Hers Health's consensus rating and price target?

According to the issued ratings of 6 analysts in the last year, the consensus rating for Hims & Hers Health stock is Buy based on the current 3 hol...

Do Wall Street analysts like Hims & Hers Health more than its competitors?

Analysts like Hims & Hers Health stock less than the stock of other Medical companies. The consensus rating score for Hims & Hers Health is 2.50 wh...

Do MarketBeat users like Hims & Hers Health more than its competitors?

MarketBeat users like Hims & Hers Health stock less than the stock of other Medical companies. 38.71% of MarketBeat users gave Hims & Hers Health a...

Does Hims & Hers Health's stock price have much upside?

According to analysts, Hims & Hers Health's stock has a predicted upside of 37.97% based on their 12-month price targets.

What analysts cover Hims & Hers Health?

Hims & Hers Health has been rated by Citigroup , Guggenheim , and Piper Sandler in the past 90 days.

Should I buy or sell Hims & Hers Health stock right now?

6 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Hims & Hers Health in the last year. There are currently 3 hold r...

What is Hims & Hers Health's stock price forecast for 2022?

6 Wall Street research analysts have issued 1-year target prices for Hims & Hers Health's shares. Their forecasts range from $6.00 to $12.00. On av...

How has Hims & Hers Health's stock price performed in 2022?

Hims & Hers Health's stock was trading at $6.55 at the start of the year. Since then, HIMS shares have decreased by 41.2% and is now trading at $3....

When is Hims & Hers Health's next earnings date?

Hims & Hers Health is scheduled to release its next quarterly earnings announcement on Wednesday, August 10th 2022. View our earnings forecast for...

How were Hims & Hers Health's earnings last quarter?

Hims & Hers Health, Inc. (NYSE:HIMS) posted its quarterly earnings data on Monday, May, 9th. The company reported ($0.08) earnings per share for th...

What guidance has Hims & Hers Health issued on next quarter's earnings?

Hims & Hers Health updated its second quarter 2022 earnings guidance on Monday, June, 6th. The company provided earnings per share guidance of for...

Who are Hims & Hers Health's key executives?

Hims & Hers Health's management team includes the following people: Mr. Andrew Dudum , Co-Founder, Director & CEO (Age 33, Pay $627.39k) ( Linke...

Who are some of Hims & Hers Health's key competitors?

Some companies that are related to Hims & Hers Health include Cano Health (CANO) , 1Life Healthcare (ONEM) , AirSculpt Technologies (AIRS) , On...

What is Hims & Hers Health's stock symbol?

Hims & Hers Health trades on the New York Stock Exchange (NYSE) under the ticker symbol "HIMS."

About Hims & Hers Health

Hims & Hers Health, Inc. operates a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals. The company offers a range of health and wellness products and services available for purchase on its websites directly by customers.

Headlines

Thinking About Buying Stock In MercardoLibre, Diamondback Energy Or Hims & Hers Health?

Hims & Hers Health (NYSE:HIMS) Frequently Asked Questions

6 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Hims & Hers Health in the last twelve months. There are currently 3 hold ratings and 3 buy ratings for the stock.

Hims & Hers stock pops on rosy revenue outlook

Yahoo Finance's Brian Sozzi and Julie Hyman break down the latest quarterly earnings for health company Hims & Hers.

Hims & Hers Health, Inc. Reports Fourth Quarter and Full Year 2021 Financial Results and Provides First Quarter and Full Year 2022 Outlook

SAN FRANCISCO, February 22, 2022--Hims & Hers Health, Inc. Reports Fourth Quarter and Full Year 2021 Financial Results and Provides First Quarter and Full Year 2022 Outlook.

Recently Viewed Tickers

Visit a quote page and your recently viewed tickers will be displayed here.

Hims & Hers Health Inc

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Stock Price Forecast

The 5 analysts offering 12-month price forecasts for Hims & Hers Health Inc have a median target of 8.00, with a high estimate of 10.00 and a low estimate of 5.75. The median estimate represents a +68.42% increase from the last price of 4.75.

Analyst Recommendations

The current consensus among 5 polled investment analysts is to Buy stock in Hims & Hers Health Inc. This rating has held steady since November, when it was unchanged from a Buy rating. Move your mouse over past months for detail